Sorry, you need to enable JavaScript to visit this website.

XALKORI (crizotinib) Overdosage

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Overdosage

The recommended 250 mg BID dosing regimen was the maximum tolerated dose for XALKORI determined in a Phase 1 dose-escalation study in patients with advanced solid tumors.  Treatment of overdose with XALKORI should consist of symptomatic treatment and other supportive measures.  There is no antidote for XALKORI.

For management of a suspected drug overdose, contact your regional Poison Control Centre.

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111